Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.46 |
| ▸ | ACP3 | P15309 | 9/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL232549 | 0.82 | SRC (0.60) | SRCANPEPACP3 | |
| SCHEMBL6030734 | 0.82 | SRC (0.54) | SRCANPEPACP3ALDH1A1CA2 | |
| SCHEMBL28543474 | 0.80 | SRC (0.58) | SRCANPEPACP3 | |
| SCHEMBL11775225 | 0.78 | SRC (0.50) | SRCANPEPACP3ALDH1A1 | |
| Potassium Ion SCHEMBL10975285 | 0.78 | SRC (0.50) | SRCANPEPACP3ALDH1A1CA2 | |
| SCHEMBL28467116 | 0.77 | SRC (0.46) | SRCANPEPACP3ALDH1A1POLB | |
| SCHEMBL18893729 | 0.75 | SRC (0.47) | SRCANPEPACP3ALDH1A1POLB | |
| SCHEMBL7746267 | 0.75 | SRC (0.47) | SRCANPEPACP3POLB | |
| Phosphoric Acid SCHEMBL28355238 | 0.75 | SRC (0.56) | SRCANPEPACP3ALDH1A1CA2 | |
| Isopropylbenzene SCHEMBL11472092 | 0.75 | SRC (0.56) | SRCANPEPACP3CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5574024-A | Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism | EBETINO FRANK H (US) | 1996-11-12 | — | — | US | disclosed |
| EP-0298553-B1 | METHYLENE PHOSPHONOALKYLPHOSPHINATES, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM | Norwich Eaton Pharmaceuticals, Inc. (US) | 1992-01-15 | — | — | EP | disclosed |
| EP-0298553-A1 | Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism | Norwich Eaton Pharmaceuticals, Inc. (US) | 1989-01-11 | — | — | EP | disclosed |